Insilico Medicine Inc.
Insilico Medicine is a bioinformatics company leading the field of geroscience and personalized medicine. The company develops novel aging biomarkers, geroprotectors and new tools for aging research. Insilico Medicine is focused on drug repurposing, pathway activation analysis and deep learning AI systems. The company also provides services to pharmaceutical, cosmetics, nutraceutical and personalized medicine companies.Visit site
Led by Dr. Anthony Atala of Wake Forest University, Atlas Regeneration is dedicated to the development of novel data-driven solutions for regenerative medicine. The company is adapting a multiomics-wide view of stem cell quality and cell fate design. The core offering
is a global comprehensive map of stem cell differentiation, Universal Signalome
Atlas for Regenerative Medicine, that reflects the pathway activation states across
all characterized stem cells and their differentiated products.
Key applications of the Universal Signalome Atlas for Regenerative Medicine will include quality assurance for engineered cell products, and directed regeneration pharmacology, where screening and identifying the compounds can efficiently convert pluripotent cells into desired subtypes. Another marketable piece of IP is the development of specialized signaling pathway analysis through systems Regeneration Intelligence which supposed to target and predict stem cell signaling pathway activation which enables to govern cell differentiation in specific directions.
VITAL (Validating Investment Tool for Advancing Life Sciences) is an artificial intelligence (AI) system that enables firms to screen hundreds of start-ups, private and public companies in the life science sector by evaluating market size, technology potential and company prospects.Visit site
OncoFinder is a system of personalized chemotherapy selection for people with cancer based on the analysis of transcriptome data and intracellular signaling pathways of the patient. The system increases the effectiveness of chemotherapy assigned by the formula selection according to the individual characteristics of the patient's tumor which reduces the toxic side effects of the treatment.Visit site
Pathway Pharmaceuticals is a Hong Kong-based personalized medicine company with a primary focus on oncology. The company provides solutions that assist individual patients in making well-informed decisions of cancer therapy selection.
The company’s core project is OncoFinder - a clinical decision-making support system, which uses Big Data bioinformatics, molecular analysis, and genetics to provide a complete analysis of patient’s cancer condition to offer the most efficient personalized treatment.
Vision Genomics is a biotechnology company that focuses on research and development of therapeutics for age-related eye diseases by undertaking interdisciplinary approach using big data analysis to produce working solutions.
Pharma.AI is a deep learning knowledge management system. Pharma. It utilizes the latest advances in deep learning to improve computer analysis of massive multi-omics data and millions of tissue-specific pathway activation profiles obtained using proprietary methods developed by the company.Visit site
Canada Cancer and Aging Research Laboratories
Canada Cancer and Aging Research Laboratories (CCARL) is a research and development company that offers a personalized approach to cancer treatment. Empowered by decades of knowledge on molecular signatures of various cancers, sex-and age-specificity of cancer response to the treatment, molecular and biochemical characteristics of regulation of various pro- and anti-cancer pathways, CCARL has been able to generate a product that allows doctors to make case-by-case decisions regarding personalized patient treatment.Visit site
Insilico Medicine Inc. is a bioinformatics company in the field of geroscience and personalized medicine that is committed to extension of human longevity. It focuses on developing diseases and aging biomarkers, geroprotectors, and new tools for aging research using best practices from academia and IT. Insilico Medicine is an expert in drug repurposing, pathway activation analysis and deep learning tools. It provides services to pharmaceutical, cosmetics, nutraceutical and personalized medicine companies.Visit site
Embryonic AI has developed the first deep learning classifier designed to identify the "embryonic score" of a biological sample. The system gives a comprehensive metric that shows how close your sample is to an embryonic state. Embryonic AI is an ensemble of deep neural networks trained and validated by thousands of transcriptomics samples.Visit site
The Global Longevity Initiative aims to extend the period of healthy longevity to 100 years and beyond. The initiative is an international partnership between the world leading universities, governmental agencies, biotech, and pharmaceutical companies that aims to create the science, technology, and commercialization hubs in the field of preventative and personalized medicine all around the globe.
An international initiative that challenges people to live longer. SuperCentenarians includes a longevity advice and a $1 million prize to the first person to reach 123 years of age.Visit site
The Biogerontology Research Foundation
The Biogerontology Research Foundation (BGRF) is a UK non-profit research foundation working to galvanize a paradigm shift in modern medicine away from single disease treatment toward personalized multi-disease prevention, utilizing advancements in geroscience to ameliorate the forms of damage underlying the ageing process in order to maximize healthspan and prevent the occurrence of age-related disease, which accounts for the majority of chronic diseases afflicting developed nations today. The BGRF is active in the areas of basic scientific research, public policy and healthcare regulatory reform, and the clinical translation of effective geroscience therapies. They are what you might call a smart charity - focusing on problems where they can have maximum impact per pound spent.Visit site